An Open-Label, Randomized, 4 Period Crossover, Replicate Study to Assess the Relative Bioavailability of the Phase III and Phase IIb Formulations of AZD5672 in Healthy Male and Female Subjects.
Phase of Trial: Phase I
Latest Information Update: 09 Dec 2009
At a glance
- Drugs AZD 5672 (Primary)
- Indications Rheumatoid arthritis
- Focus Pharmacokinetics
- Sponsors AstraZeneca
- 01 Jul 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 08 Apr 2009 New trial record